CLINICAL_TRIALS
trial_result
· 2018-03-22
Clinical Trial Update: Subthalamic Nucleus (STN) Stimulation and Obsessive-Compulsive Disorder (OCD) [Phase 1, Phase 2]
Summary
A clinical trial evaluating subthalamic nucleus stimulation for obsessive-compulsive disorder completed Phase 1 and Phase 2.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Marie-laure Welter | Conditions: Obsessive Compulsive Disorder | Phase 1, Phase 2 | Status: COMPLETED